Patent details
EP3500575 Title: CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF
Basic Information
- Publication number:
- EP3500575
- PCT Application Number:
- IB2017054955
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP178411724
- PCT Publication Number:
- WO2018033853
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF
- French Title of Invention:
- FORME CRISTALLINE DE (S)-7-(1-ACRYLOYLPIPÉRIDIN-4-YL)-2-(4-PHÉNOXYPHÉNYLE)-4,5,6,7-TÉTRA-HYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE, SA PRÉPARATION ET SES UTILISATIONS
- German Title of Invention:
- KRISTALLINE FORM VON ((S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-A]PYRIMIDIN-3-CARBOXAMID, HERSTELLUNG UND VERWENDUNGEN DAVON
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 04/12/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 09/01/2026
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/11/2025
- Unitary Effect Registration Date:
- 09/01/2026
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 15/08/2017
- Grant date:
- 05/11/2025
- EP Publication Date:
- 26/06/2019
- PCT Publication Date:
- 22/02/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/11/2025
- EP B1 Publication Date:
- 05/11/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 15/08/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/11/2025
- Name:
- BeOne Medicines I GmbH
- Address:
- Aeschengraben 27, 4051 Basel, Switzerland (CH)
History of Owners
- From:
- 29/10/2025
- To:
- 28/11/2025
- Name:
- BeiGene Switzerland GmbH
- Address:
- Aeschengraben 27, 4051 Basel, Switzerland (CH)
Inventor
1
- Name:
- GUO, Yunhang
- Address:
- China (CN)
2
- Name:
- WANG, Zhiwei
- Address:
- China (CN)
3
- Name:
- SHI, Gongyin
- Address:
- China (CN)
Priority
- Priority Number:
- PCT/CN2016/095510
- Priority Date:
- 16/08/2016
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
Classification
- IPC classification:
- C07D 487/04; A61K 31/519; A61P 37/00; A61P 29/00; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202545
- Publication date:
- 05/11/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202609
- Publication date:
- 25/02/2026
- Description:
- Document reprinted after correction (B8, B9)
3
- Issue number:
- 202601
- Publication date:
- 31/12/2025
- Description:
- Change of owner's name or address
4
- Issue number:
- 202602
- Publication date:
- 07/01/2026
- Description:
- Unitary Effect Request Receipt
5
- Issue number:
- 202607
- Publication date:
- 11/02/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|